Diagnosis and treatment of herpangina: Chinese expert consensus

Hui Yu1, Xingwang Li2, Quanbo Liu3, Huiling Deng4, Gang Liu5, Rongmeng Jiang2, Jikui Deng6, Yingzi Ye1, Jian Hao7, Yinghu Chen8, Guangmin Nong9, Zhao-Bo Shen10, Changshan Liu11, Yingxue Zou12, Jinzhun Wu13, Xingdong Wu14, Bi-Quan Chen15, Rong Luo16, Aiwei Lin17, Yan Chen18, Xiaodong Liu2
1Department of Infectious Diseases, Children’s Hospital of Fudan University, Shanghai, China
2Infectious Disease Diagnosis and Treatment Center, Beijing Ditan Hospital Capital Medical University, Beijing, China
3Department of Infectious Diseases, Children’s Hospital of Chongqing Medical University, Chongqing, China
4Department of Infectious Diseases, The Children’s Hospital of Xi ‘an, Xi’an, China
5Department of Infectious Diseases, Beijing Children’s Hospital, Capital Medical University, Beijing, China
6Department of Infectious Diseases, Shenzhen Children’s Hospital, Shenzhen, China
7Department of Internal Medicine, Children’s Hospital of Kaifeng City, Kaifeng, China
8Department of Infectious Diseases, The Children’s Hospital-Zhejiang University School of Medicine, Hangzhou, China
9Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China
10Pneumology Department, Henan Children’s Hospital, Henan, China
11Department of Pediatrics, The Second Hospital of Tianjin Medical University, Tianjin, China
12Department of Infectious Diseases, Tianjin Children’s Hospital, Tianjin, China
13Department of Pediatric Pneumology, The First Affiliated Hospital of Xiamen University, Xiamen, China
14Department of Pediatrics, Xiamen Maternal and Child Health Care Hospital, Xiamen, China
15Department of Infectious Diseases, Anhui Provincial Children’s Hospital, Hefei, China
16Department of Infectious Diseases, Hunan Children’s Hospital, Hunan, China
17Department of Infectious Diseases, Qilu Children’s Hospital of Shandong University, Shandong, China
18Department of Pediatrics Internal Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chen C. Clinical and epidemiological features of herpangina. Inter J Epidemiol Infect Dis. 2016;43:270–3 (in Chinese).

Jiang DF, Shen KL, Shen Y. Zhu futang practice of pediatrics. 8th ed. Beijing: People’s Medical Publishing House; 2015 (in Chinese).

Li JM, Li L, Gao L, Dong XC, Liu H. Characteristics of herpangina epidemic and related environmental impact factors in Tianjin. J Environ Health. 2018;35:326–9 (in Chinese).

Li W, Gao HH, Zhang Q, Liu YJ, Tao R, Cheng YP, et al. Large outbreak of herpangina in children caused by enterovirus in summer of 2015 in Hangzhou China. Sci Rep. 2016;6:35388.

Peng Q, Xie MY, Zhang YH, Liu Q, Li WR, Li SP, et al. Molecular epidemiology of the enteroviruses associated with hand, foot and mouth disease/herpangina in Dongguan, China, 2015. Arch Virol. 2016;161:3463–71.

Yao X, Bian LL, Lu WW, Li JX, Mao QY, Wang YP, et al. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013–2014. Hum Vaccin Immunother. 2017;13:823–30.

Zeng HR, Zheng HY, Liu L, Lu J, Tan XH, Sun LM, et al. Etiological characteristics of herpangina cases in Guangzhou city in Guangdong province, 2015. Chin J Exp Clin Virol. 2017;31:409–13 (in Chinese).

Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalenceand characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenzalike illness in Thailand, 2012. PLoS One. 2014;906:9888.

Li XW, Ni X, Qian SY, Wang Q, Jiang RM, Xu WB, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018;36:257–63.

Wang WP, Sun K, Chang LW. Pediatrics. In: Qu SQ, editor. Acute upper respiratory infection. 9th ed. Beijing: People’s Medical Publishing House; 2018. p. 240–2 (in Chinese).

Takechi M, Fukushima W, Nakano T, Inui1 M, Ohfuji S, Kase T, et al. Nationwide Survey of Pediatric inpatients with hand, foot, and mouth disease, herpangina, and associated complications during an epidemic period in Japan: estimated number of hospitalized patients and factors associated with severe cases. J Epidemiol; 2018.

Deng HL, Jiang RM, Li XW, Qian SY, Wang Q, Chen Q, et al. Differential diagnosis of hand-foot-mouth disease. Chin J Clin. 2018;46:760–3 (in Chinese).

Lin H, Huang L, Zhou J, Lin KC, Wang HJ, Xue X, et al. Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial. Arch Virol. 2016;161:1–8.

Yao TX, Liao YN, Gu F, Yu SJ, Yin F. Clinical effect of recombinant human interferon α-2b spray on herpangina in children. Chin Pediatr Integr Tradit West Med. 2017;9:427–9 (in Chinese).

Mangan NE, Fung KY. Type I interferons in regulation of mucosal immunity. Immunol Cell Biol. 2012;90:510–9.